• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    CHARIOTMS - CLADRIBINE TO HALT DETERIORATION IN PEOPLE WITH ADVANCED MULTIPLE SCLEROSIS (PWAMS) 
    •   QMRO Home
    • Blizard Institute
    • Centre for Neuroscience, Surgery and Trauma
    • CHARIOTMS - CLADRIBINE TO HALT DETERIORATION IN PEOPLE WITH ADVANCED MULTIPLE SCLEROSIS (PWAMS)
    •   QMRO Home
    • Blizard Institute
    • Centre for Neuroscience, Surgery and Trauma
    • CHARIOTMS - CLADRIBINE TO HALT DETERIORATION IN PEOPLE WITH ADVANCED MULTIPLE SCLEROSIS (PWAMS)
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    CHARIOTMS - CLADRIBINE TO HALT DETERIORATION IN PEOPLE WITH ADVANCED MULTIPLE SCLEROSIS (PWAMS)

    Volume
    93
    DOI
    10.1136/jnnp-2022-abn2.197
    Issue
    9
    ISSN
    0022-3050
    Metadata
    Show full item record
    Authors
    Schmierer, K; Baker, D; Nawaz, T; Allen-Philbey, K; Barkhof, F; Chataway, J; Hooper, R; Mihaylova, B; Hobart, J; Pavitt, S
    URI
    https://qmro.qmul.ac.uk/xmlui/handle/123456789/80209
    Collections
    • Centre for Neuroscience, Surgery and Trauma [1211]
    Copyright statements
    © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.